Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,099.40
+4.70 (0.43%)
Oct 28, 2025, 3:30 PM IST
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
11.56M INR
Profits / Employee
1.22M INR
Market Cap
638.53B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Biocon | 16,315 |
| Glenmark Pharmaceuticals | 15,800 |
Aurobindo Pharma News
- 5 days ago - Aurobindo Pharma expands global footprint, incorporates new subsidiary in Chile to strengthen Latin American presence - Business Upturn
- 4 weeks ago - Why are Aurobindo Pharma shares falling over 2% today? Explained - Business Upturn
- 4 weeks ago - Gland Pharma down 4%, Sun Pharma slips 2.6%, Dr Reddy’s down 2%, Zydus nearly 3%, Aurobindo down 2% as Trump’s 100% pharma tariff jolts sector - Business Upturn
- 4 weeks ago - Indian pharma stocks in focus as Trump announces 100% tariff on branded drugs - Business Upturn
- 5 weeks ago - Aurobindo Pharma reports fire incident at its Andhra Pradesh unit - Business Upturn
- 5 weeks ago - Aurobindo Pharma’s CuraTeQ Biologics successfully completes Phase 3 study for denosumab biosimilar - Business Upturn
- 5 weeks ago - Top stocks to watch today, September 18: TVS Motor, Biocon, Aurobindo Pharma, Bandhan Bank, Federal Bank and more - Business Upturn
- 6 weeks ago - Why are Aurobindo Pharma shares up 5% today? Know More - Business Upturn